Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 99376912 | 9937691 | 2 | F | 20140219 | 20140303 | 20160831 | EXP | US-ROCHE-1353719 | ROCHE | 0.00 | F | Y | 77.20000 | KG | 20160831 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 99376912 | 9937691 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | 744880,913147,744880,923422,930817, | 103976 | 150 | MG | SOLUTION FOR INJECTION | ||||||
| 99376912 | 9937691 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | U | 744880,913147,744880,923422,930817, | 103976 | ||||||||||
| 99376912 | 9937691 | 3 | SS | TAMIFLU | OSELTAMIVIR PHOSPHATE | 1 | Oral | U | 21087 | 75 | MG | CAPSULE | QOD | ||||||
| 99376912 | 9937691 | 4 | C | ATROVENT | IPRATROPIUM BROMIDE | 1 | 0 | ||||||||||||
| 99376912 | 9937691 | 5 | C | KENALOG | TRIAMCINOLONE ACETONIDE | 1 | 0 | ||||||||||||
| 99376912 | 9937691 | 6 | C | ALBUTEROL. | ALBUTEROL | 1 | Nasal | 0 | .083 | PCT | |||||||||
| 99376912 | 9937691 | 7 | C | FLONASE (UNITED STATES) | 2 | Nasal | 0 | 50 | UG | BID | |||||||||
| 99376912 | 9937691 | 8 | C | FLOVENT HFA | FLUTICASONE PROPIONATE | 1 | Nasal | 2 PUFFS 2 TIMES A DAY | 0 | 220 | UG | BID | |||||||
| 99376912 | 9937691 | 9 | C | FOSAMAX | ALENDRONATE SODIUM | 1 | Oral | 0 | 70 | MG | TABLET | ||||||||
| 99376912 | 9937691 | 10 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 0 | 20 | MG | TABLET | QD | |||||||
| 99376912 | 9937691 | 11 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 0 | 35 | MG | TABLET | ||||||||
| 99376912 | 9937691 | 12 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Nasal | 0 | 18 | UG | QD | ||||||||
| 99376912 | 9937691 | 13 | C | VICODIN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Unknown | 0 | |||||||||||
| 99376912 | 9937691 | 14 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | 0 | 10 | MG | TABLET | QD | |||||||
| 99376912 | 9937691 | 15 | C | CETRIZINE | CETIRIZINE HYDROCHLORIDE | 1 | Unknown | 0 | TABLET | ||||||||||
| 99376912 | 9937691 | 16 | C | PATADAY | OLOPATADINE HYDROCHLORIDE | 1 | Nasal | 0 | .2 | PCT | QD | ||||||||
| 99376912 | 9937691 | 17 | C | PULMICORT TURBUHALER | BUDESONIDE | 1 | Nasal | 0.5/2 MG, 1 VIAL TWICE DAILY | 0 | ||||||||||
| 99376912 | 9937691 | 18 | C | ZITHROMAX | AZITHROMYCIN DIHYDRATE | 1 | Oral | 0 | 250 | MG | TABLET | BID | |||||||
| 99376912 | 9937691 | 19 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Nasal | 230-21 MG | 0 | BID | |||||||||
| 99376912 | 9937691 | 20 | C | MAXAIR | PIRBUTEROL ACETATE | 1 | Nasal | 2 PUFFS 4-6 HOURS A DAY | 0 | ||||||||||
| 99376912 | 9937691 | 21 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | 0 | 30 | MG | QD | ||||||||
| 99376912 | 9937691 | 22 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | 2 TABS 3 TIMES A DAY | 0 | 500 | MG | TABLET | |||||||
| 99376912 | 9937691 | 23 | C | ZYFLO | ZILEUTON | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 99376912 | 9937691 | 1 | Asthma |
| 99376912 | 9937691 | 2 | Rhinitis allergic |
| 99376912 | 9937691 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 99376912 | 9937691 | HO |
| 99376912 | 9937691 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 99376912 | 9937691 | Adrenal insufficiency | |
| 99376912 | 9937691 | Asthma | |
| 99376912 | 9937691 | Chronic obstructive pulmonary disease | |
| 99376912 | 9937691 | Conjunctivitis allergic | |
| 99376912 | 9937691 | Dry skin | |
| 99376912 | 9937691 | Ear discomfort | |
| 99376912 | 9937691 | Ear pain | |
| 99376912 | 9937691 | Eye allergy | |
| 99376912 | 9937691 | Fatigue | |
| 99376912 | 9937691 | Headache | |
| 99376912 | 9937691 | Nasal polyps | |
| 99376912 | 9937691 | Nausea | |
| 99376912 | 9937691 | Palpitations | |
| 99376912 | 9937691 | Paraesthesia | |
| 99376912 | 9937691 | Paranasal sinus discomfort | |
| 99376912 | 9937691 | Pruritus | |
| 99376912 | 9937691 | Rhinorrhoea | |
| 99376912 | 9937691 | Tinnitus | |
| 99376912 | 9937691 | Tremor | |
| 99376912 | 9937691 | Vasomotor rhinitis | |
| 99376912 | 9937691 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 99376912 | 9937691 | 1 | 201106 | 201412 | 0 |